Registry on NEN Patients and COVID-19

NCT04444401 UNKNOWN

A huge number of initiatives about COVID-19 are ongoing and a growing number of publications regard the correlation between cancer patients in general and SARS-CoV-2 infection. Although it has been reported that cancer patients are at a higher risk of SARS-CoV-2 infection and COVID-19 complications, data collection about cases of NEN patients SARS-CoV-2 positive are scattered and related to single countries or institutions. Because of that and due to the rarity and heterogeneity of NEN it will be hard to have homogeneous, reliable, representative and reproducible data for drawing adequate clinical recommendations about NEN patients and COVID-19. Therefore we propose a global collection of data through an international database to describe and monitor NEN patients with SARS-CoV-2 infection. This retrospective/prospective collection of data can create a solid basis to check frequence of events, clinical management, clinical outcome, demographic, geographical, clinical and biological correlations. This will be helpful for the clinical and scientific community to get reliable information for a homogeneous clinical management of NEN patients during COVID-19 pandemic. The main goal is to get the as wide as possible representativity of the world situation.

Details

Lead sponsor	European Institute of Oncology
Status	UNKNOWN
Enrolment	50
Start date	Mon Jun 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Fri Dec 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Neuroendocrine Tumors
• COVID-19

Countries

Italy